
UniQuest, AstraZeneca Collaborate on Open Innovation
The University of Queensland website reported that the pharmaceutical company AstraZeneca and the research company UniQuest have formed an open innovation program to support academic research that holds promise of new therapeutic drugs. Dr Dean Moss, chief executive officer of UniQuest said the agreement would give researchers access to high-quality
Comments Off on UniQuest, AstraZeneca Collaborate on Open Innovation • Read this story »